FDA extends impurity data submission deadline for drugmakers
It's been more than six years since the FDA found potentially cancer-causing impurities, known as nitrosamines, in drugs to treat high blood pressure and heart failure. And yet, the agency announced this week that it' ...
It's been more than six years since the FDA found potentially cancer-causing impurities, known as nitrosamines, in drugs to treat high blood pressure and heart failure. And yet, the agency announced this week that it' ...
